|

SGT-53 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Early 1: 1

Top Sponsors

  • Children's National Research Institute1

Indications

  • Embryonal Neoplasm1
  • CNS Malignancies1
  • ATRT Recurrent1
  • Ependymoma Recurrent1
  • High Grade Gliomas1

Washington D.C., District of Columbia1 trial

A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.

Children's National Hospital

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.